Use of hCG in controlled ovarian hyperstimulation
US7405197B2 · kind B2 · utility
3Cited by
2References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 12, 2002 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Sep 21, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a protocol leading to improved embryo implantation rates and/or decreased miscarriage rates in which hCG, or a bio-analogue, is administered during the follicular phase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.